North East and North Cumbria Formulary


	North East and North Cumbria ICS Formulary

Search

Results

Looking for Ivacaftor found 14 matches

Open monograph to display formulary status		BNF Category
	Ivacaftor	Respiratory system - Mucolytics - 03.07
	Lumacaftor and Ivacaftor (Orkambi^®)	Respiratory system - Mucolytics - 03.07
	Tezacaftor and Ivacaftor (Symkevi^®)	Respiratory system - Mucolytics - 03.07
	Tezacaftor with Ivacaftor and elexacaftor (Kaftrio^®)	Respiratory system - Mucolytics - 03.07

Links

Link to Drug Section

Link to document

Commissioning statement: Ivacaftor, tezacaftor/ivacaftor, lumacaftor/ivacaftor and elexacaftor/tezacaftor/ivacaftor for cystic fibrosis (03.07)

Commissioning statement: Ivacaftor, tezacaftor/ivacaftor, lumacaftor/ivacaftor and elexacaftor/tezacaftor/ivacaftor for cystic fibrosis (03.07)

Commissioning statement: Ivacaftor, tezacaftor/ivacaftor, lumacaftor/ivacaftor and elexacaftor/tezacaftor/ivacaftor for cystic fibrosis (03.07)

Commissioning statement: Ivacaftor, tezacaftor/ivacaftor, lumacaftor/ivacaftor and elexacaftor/tezacaftor/ivacaftor for cystic fibrosis (03.07)

MHRA Drug Safety Update (Feb 2022): Ivacaftor, tezacaftor, elexacaftor (Kaftrio▼) in combination with ivacaftor (Kalydeco): risk of serious liver injury; updated advice on liver function testing (03.07)

MHRA Drug Safety Update (Feb 2022): Ivacaftor, tezacaftor, elexacaftor (Kaftrio▼) in combination with ivacaftor (Kalydeco): risk of serious liver injury; updated advice on liver function testing (03.07)

MHRA: Kaftrio▼ (Ivacaftor, tezacaftor, elexacaftor): risk of psychological side effects (03.07)

NICE TA988: Ivacaftor–tezacaftor–elexacaftor, tezacaftor–ivacaftor and lumacaftor–ivacaftor for treating cystic fibrosis (03.07)

TA988: Ivacaftor–tezacaftor–elexacaftor, tezacaftor–ivacaftor and lumacaftor–ivacaftor for treating cystic fibrosis (03.07)

TA988: Ivacaftor–tezacaftor–elexacaftor, tezacaftor–ivacaftor and lumacaftor–ivacaftor for treating cystic fibrosis (03.07)